KalVista Pharmaceuticals, Inc. (KALV)
SEC fundamentals · as filed in 10-Q FY2026, period ended Mar 31, 2026 · updated Oct 7, 2026
as filed in 10-Q FY2026, period ended Mar 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Mar 31, 2026, KalVista Pharmaceuticals, Inc. reported revenue of $40.9M, net income of -$23.5M, and total assets of $328.9M. Every figure below is taken directly from KalVista Pharmaceuticals, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2024 · as reported
- FY2016 revenue
- $2.1M
- FY2024 revenue
- $50.0M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | — | -$183.4M |
| FY2024 | $50.0M | -$126.6M |
| FY2023 | — | -$92.9M |
| FY2022 | — | -$82.3M |
| FY2021 | — | -$46.2M |
| FY2020 | $12.7M | -$29.1M |
| FY2019 | $16.1M | -$20.8M |
| FY2018 | $8.4M | -$15.8M |
| FY2017 | $1.5M | -$18.6M |
| FY2016 | $2.1M | -$11.4M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Jun 11, 2026 | on EDGAR ↗ |
| 10-Q | May 14, 2026 | on EDGAR ↗ |
| 8-K | Apr 29, 2026 | on EDGAR ↗ |
| 8-K | Mar 25, 2026 | on EDGAR ↗ |
| 8-K | Jan 8, 2026 | on EDGAR ↗ |
| 8-K | Nov 10, 2025 | on EDGAR ↗ |
| 10-Q | Nov 10, 2025 | on EDGAR ↗ |
| 8-K | Oct 6, 2025 | on EDGAR ↗ |
| 8-K | Oct 2, 2025 | on EDGAR ↗ |
| 8-K | Sep 29, 2025 | on EDGAR ↗ |
Balance Sheet
as of Mar 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Mar 31, 2026
| Revenue | $40.9M | Revenue | source ↗ |
| Net Income | -$23.5M | Net | source ↗ |
| Operating Income | -$23.4M | Operating | source ↗ |
| Gross Profit | $37.8M | Revenue−Cost | source ↗ |
| Cost of Revenue | $3.1M | Cost | source ↗ |
| R&D Expense | $12.4M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Mar 31, 2026
| EPS (diluted) | $-0.43 | Earnings | source ↗ |
| EPS (basic) | $-0.43 | Earnings | source ↗ |
| Shares Outstanding | 53.2M | Entity | source ↗ |
| Cash from Operations | -$14.5M | Net | source ↗ |
| Cash from Financing | $1.5M | Net | source ↗ |
| Cash from Investing | -$901,000 | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 13
- Net shares
- -65.4K
Restatement history
Point-in-timeNo material restatements detected across 294 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches KALV’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KALV
MCP tool:
get_sec_fundamentals ticker=KALV - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KALV/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=KALV as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KALV/history
MCP tool:
get_fundamentals_history ticker=KALV - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/KALV
MCP tool:
get_financial_health ticker=KALV
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.